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ABSTRACT
Amitraz is a widely available insecticide but whose 
human poisoning is highly under-recognized and 
mistaken for organophosphate poisoning. As a 
result, it is often mismanaged possibly resulting in 
suboptimal clinical outcomes. We present a case of a 
55-year-old man who ingested Amitraz pesticide 3 
hours prior to admission following a suicide attempt. 
His clinical condition rapidly deteriorated 
necessitating admission to the Intensive Care Unit. 
As there is no known effective antidote for human 
Amitraz poisoning in current medical practice, he 
was managed supportively but with excellent 
clinical outcome. Despite the lack of an effective 
antidote for human Amitraz poisoning, appropriate 
supportive management yields excellent clinical 
outcomes. However, misdiagnosis and incorrect 
treatment may result in severe effects on the body 
systems causing coma and respiratory failure which 
often yields fatal outcome especially in resource-
limited settings like Zambia.
INTRODUCTION
Amitraz is a formamidine derivative insecticide that 
dissolves in organic solvents acetone, toluene and 
xylene. It works as an á2 agonist in the central 
nervous system (CNS) and an á  and á  agonist 2 1
1peripherally .  It also causes inhibition of both 
Monoamine Oxidase (MAO) and prostaglandin E  2
synthesis. The clinical presentation of Amitraz 
poisoning often has CNS, cardiovascular, 
respiratory, urinary, gastrointestinal and metabolic 
features.
Amitraz is normally sold as a 12.5 to 50% 
formulation dissolved in an organic solvent mostly 
1,5Xylene . It is used as an ectoparasite to control 
Demodicosis in canines, ticks and mites in cattle and 
sheep, Psylla in pears and also Red Spider infection 
1-6in fruit crops . Human exposure can be intentional 
or accidental via inhalation, skin contact or 
1,4ingestion . 
Few cases have been reported in Sub-Saharan 
Africa. For example, a systematic review by 
Dhooria et al showed that only 69 cases have been 
reported in South Africa as of the year 2011 and 1 
7case in Kenya as of the year 2012 . Despite being a 
common pesticide used among most small-scale 
farmers in Zambia, there is little awareness of 
Amitraz poisoning and subsequent management. 
The poisonous effect may be misconstrued either as 
organophosphate or carbamate poisoning in view of 
similarities in clinical presentation. We present a 
case of a 55-year-old Zambian man with Amitraz 
poisoning.
Case presentation
A 55-year-old Zambian man presented to the 
Emergency Department of Livingstone Central 
Hospital (LCH), a tertiary institution in the Southern 
Province of Zambia, with a history of having 
ingested an unknown quantity of Amitraz (brand 
name Triatix) 3 hours before presentation. He had 
ingested the poison in a suicidal attempt following a 
domestic dispute. The patient was initially rushed to 
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a local primary health facility after he reported 
having ingested all contents of a full bottle of 
Amitraz. He was said to have been given activated 
charcoal and later referred to this hospital. There was 
no history of vomiting, diarrhea or copious 
secretions from the mouth or nose. 
On presentation to the Emergency Department 
(ED), the patient was semi-conscious with a 
Glasgow Coma Scale (GCS) of 10/15 (Motor-6, 
Verbal-2, Eyes-2) with pinpoint pupils bilaterally. 
He had no secretions, and the lungs were clear on 
auscultation. However, the peripheral oxygen 
saturation (SPO ) was 86-88% on ambient air. The 2
respiratory rate was 20 breaths per minute. The 
blood pressure was not recordable with a feeble 
pulse of 70 beats per minute. The heart sounds were 
regular. The patient was hypothermic with a 
otemperature of 35.2 C. The abdomen was distended 
with sluggish bowel sounds. Tendon reflexes were 
normal. Based on these findings, the patient was 
presumed to have organophosphate poisoning 
(OPP). 
He was immediately given oxygen at 4 liters /minute 
via nasal prongs with an improvement of the SPO  to 2
99%. The patient was given 6mg of atropine over a 
period of 10 minutes, however, when the bottle of 
contents was reviewed, the diagnosis of OPP was 
disregarded and atropine treatment was immediately 
stopped. An infusion of 0.9% saline was also given 
at 40mls/kg over 1 hour with an improvement of 
blood pressure to 84/50mmHg and a mean arterial 
pressure (MAP) of 61. Given the inadequate MAP 
after fluid resuscitation, the patient was initiated on 
inotropic support with dopamine at 5mcg/kg/min 
which was titrated up by 2mcg/kg/min every 15 
minutes to achieve a target MAP of greater than 
70mmHg. 3 hours post-admission, the patient's level 
of consciousness deteriorated with a GCS rating 
dropping to 3/15. Pupils were dilated and 
unresponsive to light. Additionally, the patient had 
poor respiratory effort. He was therefore admitted to 
the Intensive Care Unit (ICU) in anticipation of 
respiratory failure. He later went into respiratory 
arrest and was intubated and given ventilator 
support. The circulatory shock resolved with 
dopamine but the patient remained on inotropic 
support for 48 hours. Arterial blood gases due to the 
non-availability of the service at LCH. The other 
laboratory results were as shown in Table 1.
Table 1: Results of the initially ordered laboratory 
tests
On the second day of ICU admission the patient's 
level of consciousness had improved with the GCS 
of 14/15 (Eyes-4, Motor-6, Verbal-4). However, the 
abdominal distension had increased and bowel 
sounds become sluggish so a nasogastric tube was 
inserted and the patient kept nil per os for three days. 
During this time the patient was maintained on 5% 
dextrose. The blood glucose profile remained within 
the normal range throughout the time the patient was 
admitted. There was no history of seizures 
throughout the treatment period.
The patient had made a full recovery on the fourth 
day with a steady GCS of 15/15. He had also opened 
bowels and the abdominal distension had resolved. 
He was therefore discharged from ICU and started 
on a light diet. The patient was discharged from 
thmedical care on the 5  day with no complications. 
He was seen by a qualified psychiatrist before 
discharge for psychological support. He remained 
Laboratory Parameter
 
Result Reference Range
White cell count  
Red cell count  
Hemoglobin
 
Hematocrit
 Mean corpuscular volume
 Platelets
 Neutrophils
 
Lymphocytes
 
Monocytes
 
ALP 
 
AST
ALT
Albumin 
Urea 
Creatinine 
10.40x10^9/L
4.13x10^9/L
12.1g/dL
38.3%
92.7fL
188x10^9/L
88.9%, 9.25x10^9/L
7.3%, 0.76x10^9/L
3.8%, 0.40x10^9/L
71.6 U/L
66.1U/L
65.0U/L
31.2(g/L)
7.4(mmol/L)
138.4(µmol/L)
4.00-10.00
4.89-6.11
14.3-18.3
41.0-52.0
79.1-98.9
137-373
0.96-6.40
1.01-2.97
0.08-0.61
42.0-98.0
0.0-45.0
0.0-35.0
35.0-52.0
2.80-7.10
59.0-104.0
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asymptomatic when he was reviewed at 2 weeks and 
2 months post-discharge and had continued to make 
steady progress in his social life. 
DISCUSSION
Amitraz poisoning is likely common in Zambia 
especially among rural farming communities where 
it is used for agricultural and veterinary purposes. It 
is available in various brand names and does not 
2-3require a prescription to purchase . Locally, 
insecticides used for veterinary purposes are 
collectively referred to as 'Dip' and this brings 
confusion in distinguishing different types of 
poison. As OPP is the most common poisoning, 
'Dip-poisoning' almost always refers to it. As a 
result, patients are almost always managed as OPP. 
In addition, Amitraz poisoning may present like 
2OPP . Because of these clinical similarities, our 
patient was initially thought to have OPP.
Amitraz is a formamidine that stimulates á  2
receptors in the CNS and á  and á  receptors 2 1
1-6peripherally . Because of its á  agonist effect on the 2
CNS, presentation is similar to clonidine 
2poisoning . It also causes secondary inhibition of 
6MAO and synthesis of prostaglandin E . Clinical 2
manifestations of Amitraz poisoning are due to 
these pharmacological properties as well as those of 
2organic solvents used in various preparations .
Currently, there is no antidote for treating Amitraz 
poisoning. Even though á  antagonists like 2
Yohimbine and Atipamizole have been used 
effectively in animals, there are no human trials to 
6support their use . Naloxone which is used as an 
adjunct in the management of Clonidine poisoning 
1-3,6is also not effective . Therefore, management is 
supportive as was the case with our patient. 
Clinical manifestations include CNS depression, 
drowsiness, coma, convulsions, ataxia and 
1nystagmus, irritability . Our patient presented with 
CNS depression. Initially, he had drowsiness then 
later went into a coma. There was no history of 
ataxia, nystagmus or convulsions. Ataxia and coma 
have also been attributed to solvents used for 
1-6example Xylene . Our patient's coma lasted for 36 
hours, however, other studies have shown that CNS 
3depression ranged from a few hours to 24 hours .
Other additional features such as miosis - a pre-
synaptic effect at low doses and mydriasis- a 
postsynaptic effect in high doses, absence of light 
reflexes, polyuria- due to inhibition of antidiuretic 
hormone and renin, hyperglycemia, reduced 
gastrointestinal motility and abdominal distension 
3,8have been observed . Our patient initially had 
miosis then later developed mydriasis. Although this 
can be attributed to the atropine that was initially 
given, the mydriasis persisted for over 4 hours, the 
period which is beyond the half-life of atropine 
which made us conclude that there was a possibility 
of the primary effect of the high dose of Amitraz. 
Additional reported features like respiratory 
depression, respiratory arrest, hypotension, and 
bradycardia were all present in our patient. Even 
though atropine has been used to treat bradycardia 
and myosis, its use in Amitraz poisoning remains 
questionable, hence atropine was stopped in our 
patient and replaced with dopamine which has been 
2,4shown to treat both hypotension and bradycardia .
Most literature describes the onset of action between 
1,2,630 to 180 minutes after exposure . In our patient, 
clinical features manifested within this time frame. 
However, Kalyoncu et al reported onset within 5 
minutes to 6 hours with oral ingestion and 5 minutes 
9up to 24 hours after dermal exposure . 
One of the clinical features differentiating Amitraz 
from OPP is the absence of hypersecretions. Our 
patient had no secretions at presentation and 
throughout the duration of his admission. The SPO2 
at room air was low despite the patient having clear 
lung fields on auscultation consistent with 
respiratory depression associated with Amitraz. He 
later developed respiratory arrest and required 
intubation and respiratory support; another feature 
consistent with Amitraz poisoning. 
Our patient had hypothermia at presentation but later 
developed intermittent fever which had resolved at 
the time of discharge. Most literature report 
hypothermia attributed to the inhibition of 
2,3prostaglandin E2 . However, Ulukaya et al had 
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10reported hyperthermia . Our patient also presented 
with slow gastrointestinal motility and abdominal 
distension which resolved 4 days later after 
decompression and being nil per os. Others have 
reported a rare occurrence of Ogilvie's syndrome 
(acute pseudo colonic obstruction) which requires 
6the use of neostigmine in its management .
The liver enzymes were elevated in our patient. This 
is in keeping with the report by Herath et al. 
However available evidence does not show any 
significant alteration in the Liver function tests. 
Amitraz is a potent hepatotoxic drug that decreases 
hepatic glutathione activity but liver function tests 
1,3return to normal within 48 hours . The serum 
creatinine was elevated in our patient but few 
studies have reported it and its significance is not yet 
determined. Hematological tests were all normal. 
Additionally, ECG changes reported by other 
studies which include bradycardia, ST-segment 
changes, ventricular arrhythmias and torsade de 
4pointes   were, however, not seen in our patient.
Dose intake in our patient was unknown but it can be 
deduced from the clinical presentation that the 
patient had ingested a substantial amount of 
Amitraz. The minimal toxic dose that has been 
6reported is 3.57mg/kg . Despite the severity of the 
clinical features, our patient made a full recovery on 
supportive treatment. 
CONCLUSION
In spite of there being no antidote for human 
Amitraz poisoning in current medical practice, there 
is prognosis if the patient is given supportive 
management in a high dependency setting as 
illustrated by our patient who was discharged, with 
no complications, 5 days after admission. However, 
clinicians need to be aware of the clinical 
manifestations of Amitraz and correctly identify the 
poison so as to institute correct treatment to avoid 
deleterious effects especially if there is a history 
suggestive of pesticide ingestion. 
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